Obstet Gynecol. 2023 Jun 1;141(6):1098-1114. doi: 10.1097/AOG.0000000000005212. Epub 2023 Apr 19.
To describe the psychometric properties of existing patient-reported outcome measures for women with prolapse using the COSMIN (Consensus-Based Standards for the Selection of Health Measurement Instruments) framework. Additional objectives were to describe the patient-reported outcome scoring method or interpretation, methods of administration, and to compile a list of the non-English languages in which the patient-reported outcomes are reportedly validated.
PubMed and EMBASE was searched through September 2021. Study characteristics, patient-reported outcome details, and psychometric testing data were extracted. Methodologic quality was assessed with COSMIN guidelines.
Studies reporting the validation of a patient-reported outcome in women with prolapse (or women with pelvic floor disorders that included a prolapse assessment) and reporting psychometric testing data on English-language patient-reported outcome for at least one measurement property per COSMIN and the U.S. Department of Health and Human Services definitions were included, as well as studies reporting the translation of an existing patient-reported outcome into another language, a new method of patient-reported outcome administration, or a scoring interpretation. Studies reporting only pretreatment and posttreatment scores, only content or face validity, or only findings for nonprolapse domains of the patient-reported outcome were excluded.
TABULATION, INTEGRATION, AND RESULTS: Fifty-four studies covering 32 patient-reported outcomes were included; 106 studies assessing translation into a non-English language were excluded from the formal review. The number of validation studies per patient-reported outcome (one version of one questionnaire) ranged from 1 to 11. Reliability was the most reported measurement property, and most measurement properties received an average rating of sufficient. The condition-specific patient-reported outcomes had on average more studies and reported data across more measurement properties compared with adapted and generic patient-reported outcomes.
Although measurement property data vary on patient-reported outcomes for women with prolapse, most data were of good quality. Overall, condition-specific patient-reported outcomes had more studies and reported data across more measurement properties.
PROSPERO, CRD42021278796.
使用 COSMIN（健康测量仪器选择共识标准）框架描述现有针对脱垂女性的患者报告结局测量工具的心理测量学特性。此外，还描述了患者报告结局的评分方法或解释、管理方法，并编制了一份报告验证过的非英语语言的患者报告结局清单。
通过 2021 年 9 月对 PubMed 和 EMBASE 进行了检索。提取了研究特征、患者报告结局详细信息和心理测量学测试数据。使用 COSMIN 指南评估方法学质量。
纳入了报告针对脱垂女性（或包含脱垂评估的盆底功能障碍女性）的患者报告结局验证，并报告了至少一项 COSMIN 和美国卫生与公众服务部定义的测量特性的英语患者报告结局心理测量学测试数据的研究，以及报告将现有患者报告结局翻译成另一种语言、患者报告结局管理的新方法或评分解释的研究。仅报告治疗前后评分、仅内容或表面有效性、或仅报告患者报告结局非脱垂领域结果的研究被排除在外。
列表、综合和结果：纳入了 54 项涵盖 32 项患者报告结局的研究；106 项评估翻译成非英语语言的研究从正式审查中排除。每个患者报告结局（一种问卷的一个版本）的验证研究数量从 1 到 11 不等。可靠性是报告最多的测量特性，大多数测量特性的评价等级为充足。与适应性和通用性患者报告结局相比，特定于疾病的患者报告结局平均有更多的研究和更多的测量特性报告数据。
尽管脱垂女性患者报告结局的测量特性数据各不相同，但大多数数据质量良好。总体而言，特定于疾病的患者报告结局有更多的研究和更多的测量特性报告数据。
PROSPERO，CRD42021278796。
